NeurologyLive® Staff

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 17, 2021.

The advantages of using the pyrimidine synthesis inhibitor teriflunomide to treat relapsing-remitting multiple sclerosis.

Considerations that affect which S1P receptor modulator may be used to treat relapsing-remitting multiple sclerosis, and how to best utilize them during COVID-19.

Ellie Harrington, lecturer in genetic counseling, provides answers for patients with ALS who might be unfamiliar with genetic testing and counseling.

Here's what is coming soon to NeurologyLive®.

Neurology News Network for the week ending December 11, 2021. [WATCH TIME: 4 minutes]

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 10, 2021.

What to know about using S1P receptor modulators as oral therapy for relapsing-remitting multiple sclerosis.

Experts discuss types of oral fumarates that are available to treat relapsing-remitting multiple sclerosis, and best practices for selecting an option based on trial data and clinical experience.

Here's what is coming soon to NeurologyLive®.

Neurology News Network for the week ending December 4, 2021. [WATCH TIME: 4 minutes]

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 3, 2021.

Considerations that affect recommendations for novel oral treatment for relapsing-remitting multiple sclerosis vs a more conventional option.

Best practices for talking about treatment goals and options with patients who have relapsing-remitting multiple sclerosis.

Here's what is coming soon to NeurologyLive®.

Neurology News Network for the week ending November 27, 2021.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 26, 2021.

The rationale for early treatment initiation for patients with relapsing-remitting multiple sclerosis.

The patient symptoms that help neurologists distinguish relapsing and remitting multiple sclerosis from other forms of the disease, and recommendations regarding the best timing to initiate therapy.

Here's what is coming soon to NeurologyLive®.

Neurology News Network for the week ending November 20, 2021.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 19, 2021.

Chaired by Jennifer Graves, MD, PhD, MAS, the presentations also feature UC San Diego Health experts Jenelle Raynowska, MD; Jennifer Yang, MD; and Anastasie Dunn-Pirio, MD. [WATCH TIME: 1 hour, 23 minutes]

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending November 13, 2021.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 12, 2021.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending November 6, 2021.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 5, 2021.

Robert Fox, MD, discussed what’s currently available in terms of cannabis-derived medications that treat symptoms of multiple sclerosis, and realistic possibility of another soon entering the market.